TOVX (Theriva Biologics) FCF Margin %: -818.67% (As of Mar. 2026)


TOVX Theriva Biologics Inc TOVX
28 GF Score
Price $0.24
! 3 Warning Signs
View Full Analysis

What is Theriva Biologics FCF Margin %?

Theriva Biologics TOVX -0.69% 28 FCF Margin % is -818.67% as of Mar. 2026. GuruFocus rates TOVX with a GF Score™ of 28/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Theriva Biologics ranks worse than 90% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Theriva Biologics's Free Cash Flow for the three months ended in Mar. 2026 was $-2.46 Mil. Theriva Biologics's Revenue for the three months ended in Mar. 2026 was $0.30 Mil. Therefore, Theriva Biologics's FCF Margin % for the quarter that ended in Mar. 2026 was -818.67%.

As of today, Theriva Biologics's current FCF Yield % is -131.92%.

The historical rank and industry rank for Theriva Biologics's FCF Margin % or its related term are showing as below:

TOVX' s FCF Margin % Range Over the Past 10 Years
Min: -4789.67   Med: 0   Max: 0
Current: -4789.67

TOVX's FCF Margin % is ranked worse than
90% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs TOVX: -4789.67

Theriva Biologics FCF Margin % Related Terms

Theriva Biologics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Theriva Biologics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theriva Biologics FCF Margin % Chart

Theriva Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Theriva Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -818.67

TOVX vs CALC, PHIO, PHGE: FCF Margin % Comparison

For the Biotechnology subindustry, Theriva Biologics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theriva Biologics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theriva Biologics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Theriva Biologics's FCF Margin % falls into.


TOVX
28GF Score
Theriva Biologics Inc TOVX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Theriva Biologics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Theriva Biologics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-16.704/0
= %

Theriva Biologics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.456/0.3
=-818.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -818.67% mean?
Theriva Biologics (TOVX) has a FCF Margin % of -818.67% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Theriva Biologics and its competitors. According to the industry distribution chart, Theriva Biologics ranks #864 out of 960 companies in the Biotechnology industry, placing it in the top 90%.
Is Theriva Biologics' FCF Margin % too high?
Theriva Biologics' current FCF Margin % is -818.67%. Based on the distribution chart, Theriva Biologics ranks #864 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Theriva Biologics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Theriva Biologics' FCF Margin % compare to CALC and PHIO?
According to the Biotechnology industry distribution chart, Theriva Biologics ranks #864 out of 960 companies for FCF Margin %. This places Theriva Biologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Theriva Biologics and its competitors. Theriva Biologics's current FCF Margin % is -818.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Theriva Biologics stock overvalued right now?
Theriva Biologics (TOVX) has a current FCF Margin % of -818.67%. The current FCF Margin % is -818.67%. Theriva Biologics' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Theriva Biologics (TOVX), the current FCF Margin % is -818.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Theriva Biologics Business Description

Address 9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
28GF Score

Get the complete analysis for TOVX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.24
Price